NCT03946514View on ClinicalTrials.gov

Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Hypertension
Interventions
DRUG

losartan/hydrochlorothiazide

losartan 100 mg/hydrochlorothiazide 25 mg single-pill combination

DRUG

amlodipine/hydrochlorothiazide

amlodipine besylate tablets (5 mg / tablet) + hydrochlorothiazide tablets (25 mg / tablet)

Trial Locations (1)

200025

Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT03946514 - Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients | Biotech Hunter | Biotech Hunter